Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Connect Tissue Res. 2019 Apr 22;60(6):530–543. doi: 10.1080/03008207.2019.1601183

Figure 4.

Figure 4.

Relative levels of phosphorylated:total (A) ERK 1/2 and (B) p38 MAPK in each compartment across the osteotendinous scaffold (CG, CGCaP) with (+) and without (−) CTS as determined by immunoblot immediately prior to and following the first and second strain cycles. Data expressed as mean ± SEM (n = 3). *: p < 0.05.